Analysis of papillary urothelial carcinomas of the bladder with grade heterogeneity: supportive evidence for an early role ofCDKN2Adeletions in theFGFR3pathway

Significance of a minor high-grade component in a low-grade noninvasive papillary urothelial carcinoma of bladder

(2016) Leonardo O. Reis et al.   HUMAN PATHOLOGY

Cancer statistics, 2015

(2015) Rebecca L. Siegel et al.   CA-A CANCER JOURNAL FOR CLINICIANS

Mixed low- and high-grade non-muscle-invasive bladder cancer: a histological subtype with favorable outcome

(2014) Tina Schubert et al.   WORLD JOURNAL OF UROLOGY

Mixed High and Low Grade Bladder Tumors—Are They Clinically High or Low Grade?

(2013) Ofer N. Gofrit et al.   JOURNAL OF UROLOGY

Mixed low- and high-grade papillary urothelial carcinoma: histopathogenetic and clinical significance

(2013) Kien T. Mai et al.   VIRCHOWS ARCHIV

CDKN2A homozygous deletion is associated with muscle invasion in FGFR3-mutated urothelial bladder carcinoma

(2012) Sandra Rebouissou et al.   JOURNAL OF PATHOLOGY

A Meta-Analysis of the Relationship between FGFR3 and TP53 Mutations in Bladder Cancer

(2012) Yann Neuzillet et al.   PLoS One

Clinicopathologic Characteristics of 23 Cases of Invasive Low-grade Papillary Urothelial Carcinoma

(2012) Katherine E. Watts et al.   UROLOGY

Molecular pathways of urothelial development and bladder tumorigenesis

(2010) Mireia Castillo-Martin et al.   UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS

No mutations of FGFR3 in normal urothelium in the vicinity of urothelial carcinoma of the bladder harbouring activating FGFR3 mutations in patients with bladder cancer

(2009) Wolfgang Otto et al.   INTERNATIONAL JOURNAL OF CANCER